Business Description
GB Sciences Inc
NAICS : 325411
SIC : 2836
ISIN : US3615441090
Description
GB Sciences Inc. is a US-based biotechnology company focused on developing cannabis- and cannabinoid-derived therapies. It uses plant biology, cultivation, and extraction technologies alongside biotechnology to produce medical-grade cannabis, concentrates, and formulated medicines. Its intellectual property portfolio supports drug development programs in the preclinical stage, targeting conditions such as Parkinson's disease, chronic pain, cytokine release syndrome, depression, and cardiovascular disease. The company also pursues plant-based research and licensing opportunities. Its customers and partners include research institutions, pharmaceutical developers, and the medical cannabis sector. Revenue historically derived from cannabis cultivation and product sales, though its strategic emphasis has shifted toward biopharmaceutical research and intellectual property development. The company operates primarily in the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 4.61 | |||||
9-Day RSI | 15.89 | |||||
14-Day RSI | 25.82 | |||||
6-1 Month Momentum % | 50 | |||||
12-1 Month Momentum % | 200 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -2.4 | |||||
EV-to-EBITDA | -2.4 | |||||
EV-to-Revenue | 20.96 | |||||
EV-to-FCF | -4.02 | |||||
Earnings Yield (Greenblatt) % | -41.67 | |||||
FCF Yield % | -1234.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GBLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GB Sciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.097 | ||
| EPS (TTM) ($) | -0.003 | ||
| Beta | 24.9471 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 7.93 | ||
| Volatility % | 97.13 | ||
| 14-Day RSI | 25.82 | ||
| 14-Day ATR ($) | 0.000117 | ||
| 20-Day SMA ($) | 0.000265 | ||
| 12-1 Month Momentum % | 200 | ||
| 52-Week Range ($) | 0.0001 - 0.50015 | ||
| Shares Outstanding (Mil) | 407.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GB Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GB Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2013-10-31 | 0.30 (-6.25%) | ||
| 0.02:1 Stock Split | 2008-05-05 | 0.25 (-77.27%) | ||
| 5:1 Stock Split | 2004-06-02 | 105.00 (+110.00%) |
Show
Entries
GB Sciences Inc Frequently Asked Questions
What is GB Sciences Inc(GBLX)'s stock price today?
The current price of GBLX is $0.00. The 52 week high of GBLX is $0.50 and 52 week low is $0.00.
When is next earnings date of GB Sciences Inc(GBLX)?
The next earnings date of GB Sciences Inc(GBLX) is .
Does GB Sciences Inc(GBLX) pay dividends? If so, how much?
GB Sciences Inc(GBLX) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers